NGX6 inhibits AP-1 and Ets-1 expression and down-regulates cyclin D1 in human colorectal cancer

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 6, 2009, Pages 504-514

  Peng, Ya ^a   Li, Hongtao ^a   Wu, Minghua ^b   Wang, Xiaoyan ^a   Fan, Songqing ^c   Liu, Fen ^a   Xiang, Bo ^b   Guo, Qin ^a   Tang, Xueyuan ^a   Shen, Shourong ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

AP 1; Colorectal cancer; NGX6; SAPK JNK pathway; Tissue microarray

Indexed keywords

ETS1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NGX6 PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; COLORECTAL TUMOR; DOWN REGULATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN SITU HYBRIDIZATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; IN SITU HYBRIDIZATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEIN C-ETS-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEINS;

EID: 68549119075     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp039     Document Type: Article

References (27)

1. Iversen LH, Harling H, Laurberg S and Wille-Jørgensen P; Danish Colorectal Cancer Group. Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: A review of evidence. Part 2: long-term outcome. Colorectal Dis 2007, 9: 38-46. (Pubitemid 44869674)
2. Lieberman D. Screening for colorectal cancer in average-risk populations. Am J Med 2006, 119: 728-735.
3. Ma J, Zhou J, Fan S, Wang L, Li X, Yan Q and Zhou M, et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis 2005, 26: 281-291. (Pubitemid 40246549)
4. Peng S, Fan S, Li X, Wang L, Liu H, Zhou M and Wang L, et al. The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor. Cancer Sci 2007, 98: 341-349.
5. Yang JB, Bin LH, Li ZH, Zhang XH, Qian J, Zhang BC and Zhou M, et al. Refined localization and cloning of a novel putative tumor suppressor gene associated with nasopharyngeal carcinoma on chromosome 9p21-22. Ai Zheng 2000, 19: 6-9.
6. Zhang XM, Wang XY, Sheng SR, Wang JR and Li J. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J Gastroenterol 2003, 9: 1729-1733.
7. Fan SQ. Screening target molecule of nasopharyngeal carcinoma by using tissue microarray analysis. Doctor Thesis of Central South University, 2006.
8. Liu F, Wang XY, Lian P, Xiao ZM, Shen SR, Ma J and Xiong W. Effect of NGX6 on gene expression profile of colon carcinoma cell line HT-29. Ai Zheng 2005, 24: 1064-1070.
9. Brigitta M, Brinkman N, Schievella AR, Lin LL and Goldfeld AE. Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2 and p38 mitogen-activated protein kinase-dependent TNF-a gene expression. J Biol Chem 1999, 274: 30882-30886.
10. Teramoto H, Crespo P, Coso OA, Igishi T, Xu N and Gutkind JS. The Small GTP-binding protein Rho activates c-Jun N-terminal Kinases/ Stress-activated Protein Kinases in human kidney 293T cells. J Biol Chem 1996, 271: 25731-25734.
11. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R and Mak TW. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 2005, 9: 1974-1979.
12. Fan SQ, Zhang WL, Xiong W, Ma J, Zhou J, Zhou M and Xiao BY, et al. A Novel tool and new methods to punch the graft tissues and make the receptive blocks for constructing the tissue microarrays. Prog Biochem Biophys 2005, 32: 474-479.
13. Fan SQ, Ma J, Zhou J, Xiong W, Xiao BY, Zhang WL and Tan C, et al. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. Hum Pathol 2006, 37: 593-605.
14. Wang XY, Shen SR, Liu HY, Zhang XM, Peng C, Huan H and Liu F, et al. Effects of NGX6 gene on cell vegetative in colon cancer cell line HT-29. Shi Jie Hua Ren Xiao Hua Za Zhi 2004, 12: 574-579.
15. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W and Leisten JC, et al. SP600125, an anthrapyrazolone inhibitor of c-Jun N terminal kinase. Proc Natl Acad Sci USA 2001, 98: 13681-13686.
16. Teraishi F, Wu S, Zhang L, Guo W, Davis JJ, Dong F and Fang B. Identification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells. Cancer Res 2005, 65: 6380-6387.
17. Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN and Kim SW et al. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines. Exp Mol Med 2006, 38: 27-35.
18. Wang XY, Shen SR, Liu F, Li XL and Fang SQ. Effects of NGX6 gene on cell cycle in colon cancer cell line HT-29. Prog Biochem Biophys 2006, 33: 45-50.
19. Xiao ZM, Shen SR, Lian P, Wang XY and Liu F. Intraspleenic tumor modle of nude mice in the anti-metastasis roles of NGX6 gene against colon cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2007, 32: 753-757.
20. Li GY, Li XL, Peng C, Li J, Zhang QH, Huang YC and Tang C, et al. The effects of NGX6 on cells from human nasopharyngeal carcinoma cell line HNE. Zhong Guo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao 2002, 18: 398-403.
21. Wang L, Ma J, Li J, Li X, Zhang Q, Peng S and Peng C, et al. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem 2005, 95: 64-73. (Pubitemid 41420216)
22. Ma J, Li J, Zhou J, Li XL, Tang K, Zhou M and Yang JB, et al. Profiling genes differentially expressed in NGX6 overexpressed nasopharyngeal carcinoma cells by cDNA array. Cancer Res Clin Oncol 2002, 128: 683-690.
23. Peng SP, Li XL, Wang L, Ou-Yang J, Ma J, Wang LL and Liu HY, et al. The role of NGX6 and its deletion mutants in the proliferation, adhesion and migration of nasopharyngeal carcinoma 5-8F cells. Oncology 2006, 71: 273-281.
24. Wu M, Huang C, Gan K, Huang H, Chen Q, Ouyang J and Tang Y, et al. LRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/ protein kinase B/nuclear factor-kB pathway. Mol Biol Cell 2006, 17: 3534-3542.
25. Fang JY and Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005, 6: 322-327.
26. Herber B, Truss M, Beato M and Müller R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 1994, 9: 2105-2107.
27. Bakiri L, Lallemand D, Bossy-Wetzel E and Yaniv M. Cell cycledependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression. EMBO J 2000, 19: 2056-2068.